Todd J. Kohn

Person

San Mateo, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compounds that inhibit MCL-1 protein
- Patent number 12,091,425
- Issue date Sep 17, 2024
- Amgen Inc.
- David Karl Bedke
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds that inhibit MCL-1 protein
- Patent number 11,306,107
- Issue date Apr 19, 2022
- Amgen Inc.
- Sean P. Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds that inhibits MCL-1 protein
- Patent number 11,224,601
- Issue date Jan 18, 2022
- Amgen Inc.
- Paul E. Harrington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds that inhibit Mcl-1 protein
- Patent number 10,821,115
- Issue date Nov 3, 2020
- Amgen Inc.
- Paul E. Harrington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds that inhibit Mcl-1 protein
- Patent number 10,632,128
- Issue date Apr 28, 2020
- Amgen Inc.
- Paul E. Harrington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinoline derivitives and their uses
- Patent number 8,940,724
- Issue date Jan 27, 2015
- Amgen Inc.
- Timothy D. Cushing
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and their uses
- Patent number 8,765,940
- Issue date Jul 1, 2014
- Amgen Inc.
- Matthew Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Conformationally constrained carboxylic acid derivatives useful for...
- Patent number 8,450,522
- Issue date May 28, 2013
- Amgen Inc.
- Sean P. Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted biphenyl GPR40 modulators
- Patent number 8,030,354
- Issue date Oct 4, 2011
- Amgen Inc.
- Sean P. Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic GPR40 modulators
- Patent number 8,003,648
- Issue date Aug 23, 2011
- Amgen Inc.
- Hilary Beck
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and their use...
- Patent number 7,745,438
- Issue date Jun 29, 2010
- Eli Lilly and Company
- Howard Barff Broughton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic GPR40 modulators
- Patent number 7,714,008
- Issue date May 11, 2010
- Amgen Inc.
- Hilary Beck
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted biphenyl GPR40 modulators
- Patent number 7,572,934
- Issue date Aug 11, 2009
- Amgen Inc.
- Sean P. Brown
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TRICYCLIC-AMIDO-BICYCLIC PRMT5 INHIBITORS
- Publication number 20240124442
- Publication date Apr 18, 2024
- Amgen Inc.
- Albert AMEGADZIE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC CARBOXAMIDE DERIVATIVES AS PRMT5 INHIBITORS
- Publication number 20240101570
- Publication date Mar 28, 2024
- Amgen Inc.
- Albert AMEGADZIE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL PRMT5 INHIBITORS
- Publication number 20230159510
- Publication date May 25, 2023
- Amgen Inc.
- Jennifer Rebecca ALLEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
- Publication number 20230052348
- Publication date Feb 16, 2023
- Amgen Inc.
- Sean P BROWN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
- Publication number 20210230189
- Publication date Jul 29, 2021
- Amgen Inc.
- Sean P. BROWN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
- Publication number 20200171043
- Publication date Jun 4, 2020
- Amgen Inc.
- Paul E. HARRINGTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
- Publication number 20190381064
- Publication date Dec 19, 2019
- Amgen Inc.
- Paul E. HARRINGTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
- Publication number 20180289720
- Publication date Oct 11, 2018
- Amgen Inc.
- Paul E. Harrington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AND THEIR USES
- Publication number 20130090323
- Publication date Apr 11, 2013
- Amgen Inc.
- Paul John Dransfield
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AND THEIR USES
- Publication number 20120094972
- Publication date Apr 19, 2012
- Amgen Inc.
- Matthew Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AND THEIR USES
- Publication number 20100331293
- Publication date Dec 30, 2010
- Amgen Inc.
- Timothy D. Cushing
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Conformationally Constrained Carboxylic Acid Derivatives Useful for...
- Publication number 20100298367
- Publication date Nov 25, 2010
- Amgen Inc.
- Sean P. Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC GPR40 MODULATORS
- Publication number 20100075974
- Publication date Mar 25, 2010
- Amgen Inc.
- Hilary Beck
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted biphenyl GPR40 modulators
- Publication number 20090137561
- Publication date May 28, 2009
- Amgen Inc.
- Sean P. Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted biphenyl GPR40 modulators
- Publication number 20090111859
- Publication date Apr 30, 2009
- Amgen Inc.
- Sean P. Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic GPR40 Modulators
- Publication number 20080090840
- Publication date Apr 17, 2008
- Amgen Inc.
- Hilary Beck
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-(2-Acylamino-1-Hydroxyethyl)-Morpholine Derivatives and Their Use...
- Publication number 20070225267
- Publication date Sep 27, 2007
- Howard Barff Broughton
- C07 - ORGANIC CHEMISTRY

Todd J. Kohn

Person

Patents Grantslast 30 patents

Compounds that inhibit MCL-1 protein

Compounds that inhibit MCL-1 protein

Compounds that inhibits MCL-1 protein

Compounds that inhibit Mcl-1 protein

Compounds that inhibit Mcl-1 protein

Quinoline derivitives and their uses

Heterocyclic compounds and their uses

Conformationally constrained carboxylic acid derivatives useful for...

Substituted biphenyl GPR40 modulators

Heterocyclic GPR40 modulators

3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and their use...

Heterocyclic GPR40 modulators

Substituted biphenyl GPR40 modulators

Patents Applicationslast 30 patents

TRICYCLIC-AMIDO-BICYCLIC PRMT5 INHIBITORS

TRICYCLIC CARBOXAMIDE DERIVATIVES AS PRMT5 INHIBITORS

NOVEL PRMT5 INHIBITORS

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

HETEROCYCLIC COMPOUNDS AND THEIR USES

HETEROCYCLIC COMPOUNDS AND THEIR USES

HETEROCYCLIC COMPOUNDS AND THEIR USES

Conformationally Constrained Carboxylic Acid Derivatives Useful for...

HETEROCYCLIC GPR40 MODULATORS

Substituted biphenyl GPR40 modulators

Substituted biphenyl GPR40 modulators

Heterocyclic GPR40 Modulators

3-(2-Acylamino-1-Hydroxyethyl)-Morpholine Derivatives and Their Use...